Josh Meyer

Proud father/husband, Radiation Oncologist @ FoxChaseCancer, bass player in and I like to eat

[Josh Meyer @joshmeyer1]

@ASTRO_org @FoxChaseCancer Incredibly humbled to be granted this honor by ASTRO and to part of such a wonderful class of fellows being inducted. Privileged to be a part of such a wonderful organization!

[Josh Meyer @joshmeyer1]

Thanks to ESTRO for providing important context to the PROSPECT study.

[Ben Slotman @bslotman]

Communication presenting scientific facts should be well balanced with headlines that inform rather than alarm.#ASCO2023 @ESTRO_RT #radonc

[Dr. Nina Niu Sanford @NiuSanford]

This type of marketing of protons doesn't instill confidence in our field IMO.

The site is aptly titled https://t.co/uOkRRZPS06

On it, there is a quiz w 4 questions (age, prior RT, tumor site), but no matter what answers you put, it tells you protons may be needed.

[ASTRO @ASTRO_org]

The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement regarding the PROSPECT clinical trial for patients with rectal cancer: https://t.co/rLSb19y0OW

[Josh Meyer @joshmeyer1]

@PrajnanDasMD Very well said!

[Josh Meyer @joshmeyer1]

@subatomicdoc @SprakerMDPhD @GI_RadOnc @Medscape @NiuSanford • How does this impact non-operative management?
• How do we treat pts with suspicious lateral LNs or other LNs not defined as perirectal in the protocol?
• While removing CRT was done in the name of QoL, do the data really support that?
Will be excited to see full QoL data!

[Josh Meyer @joshmeyer1]

@subatomicdoc @SprakerMDPhD @GI_RadOnc @Medscape @NiuSanford Very impressed with the authors who conducted a difficult study in a shifting landscape that maintained relevance when it finally came out. Results took so long bc pts did so well on both arms. As the best studies do, this one leaves me with more questions than answers:

[Josh Meyer @joshmeyer1]

@kharofaJ Very excited to see these results that have been a long time coming. I predict it will make rectal ca even MORE confusing to treat, with lots of room for additional work on patient selection

[Josh Meyer @joshmeyer1]

@MikeChuongMD @MiamiCancerInst @viewray @NiuSanford @TedHong9 @whallradonc @RadDocMReyngold @JoeHermanMD I’ve only used this once and had great results, but unfortunately they didn’t last. I didn’t target the whole pancreatic mass, just the plexus, and think the mass probably grew back and put new pressure on the plexus. I’ll do it differently next time!

[Fabio Arcidiacono @FabArcidiacono8]

@MikeChuongMD @MiamiCancerInst @viewray Excellent! LC and QoL! like killing two birds with one stone!

[Josh Meyer @joshmeyer1]

@ldawsonmd @LeilaTchelebi @kharofaJ @Dan_ChangMD @nbn426 @KrishanJethwa @NiuSanford @adapthyun @AnkerUVMRadOnc @SalmaJabbour1 @MikeChuongMD @lauren_henke @JoeHermanMD @KarynAGoodman @TedHong9 @jryckman3 @whallradonc @PrajnanDasMD @freddyeescorcia @RadDocMReyngold @themednet @NRGonc Great discussion! For our mets pts, we don’t worry about biliary tree and treat with 5 fxs. For HCC or cholangio pts we contour the CHBT and if we can’t stay under and get 50 Gy, drop to 15 fractions (with no biliary constraints).

[Josh Meyer @joshmeyer1]

@lauren_henke @MikeChuongMD @NiuSanford I have had great luck with this too!

[ProPublica @propublica]

Doctors at a major US insurance company deny tens of thousands of claims a month without even looking at patients’ files.

“We literally click & submit,” a former Cigna doctor told @ProPublica & @Capitol_Forum. “It takes all of 10 seconds to do 50 at a time.”

The inside story 🧵

[Drew Moghanaki @DrewMoghanaki]

Boom!

[Mitchell Parker, MD, PhD @Mitch_P]

ChatGPT tech could revolutionize healthcare!!! BUT what are its current shortcomings and potential DANGERS??? 🧵

[Josh Meyer @joshmeyer1]

We’re hiring for an outstanding opportunity as PI of a lab with appointments in Rad Onc and the Institute for Cancer Research at Fox Chase. Exciting collaborative atmosphere with resources and support. Please share and contact me with questions. https://t.co/wziwpFhPst

[Josh Meyer @joshmeyer1]

Temple University is tapping North Philly community members to help choose its medical students. What a great idea and fantastic use of the wonderful resource that is the Temple community! https://t.co/RLaCmd9lsi

[Fox Chase Cancer Center @FoxChaseCancer]

Researchers at Fox Chase have shown in a recent study that taking a new approach to targeting a well-established cancer-promoting pathway may be effective in stopping the progression of certain cancers. Read more about this study: https://t.co/9MgxDHgNlS

[Fox Chase Cancer Center @FoxChaseCancer]

Pancreatic cancer remains one of the most challenging cancers to fight. But improvements in a long-standing procedure are helping doctors chip away at it. Hear from Dr. @SanjaySReddy on how FCCC is treating pancreatic cancer in new ways: https://t.co/vTOfUZL999 @6abcaction

[Fumiko Ladd Chino, MD, FASCO @fumikochino]

🚨@Oncoalert:
#RadOnc is "constantly working to improve survival & patient well-being, form deep connections with our pts, & push the boundaries of medical innovations." Proud of this @Medscape column w/ Dr @fantinegiap discussing what makes #radonc unique
https://t.co/GSgS2jisRL